1 INTRODUCTION
1.1 OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.3 RESEARCH METHODOLOGY
1.3.1 SECONDARY DATA
1.3.2 PRIMARY DATA
1.3.3 MARKET SIZE ESTIMATION
1.3.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.4 STAKEHOLDERS
1.5 CURRENCY
1.6 RESEARCH ASSUMPTIONS
1.7 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 DROC MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 COST STRUCTURE ANALYSIS
3.6 VALUE CHAIN ANALYSIS
3.7 COVID-19 IMPACT ANALYSES
4 INDUSTRY TRENDS
4.1 INTRODUCTION
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES MODEL
4.3.1 DEGREE OF COMPETITION
4.3.2 BARGAINING POWER OF BUYERS
4.3.3 BARGAINING POWER OF SUPPLIERS
4.3.4 THREAT FROM SUBSTITUTES
4.3.5 THREAT FROM NEW ENTRANTS
5 BLOOD PLASMA TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2015-2019
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 НUMАN АLBUMІN
5.6 GЕLАTІNЅ
5.7 DЕХTRАNЅ
5.8 ЅTАRСHЕЅ
5.9 OTHER
6 BLOOD PLASMA MARKET MODE OF DELIVERY ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET MODE OF DELIVERY ANALYSIS, 2015-2019
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 INFUSION SOLUTIONS
6.6 GELS
6.7 SPRAYS
6.8 BIOMEDICAL SEALANTS
7 BLOOD PLASMA MARKET THERAPEUTIC INDICATION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET THERAPEUTIC INDICATION ANALYSIS, 2015-2019
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 IMMUNOLOGY
7.6 ONCOLOGY
7.7 PULMONOLOGY
7.8 RHEUMATOLOGY
7.9 TRANSPLANTATION
7.10 NEUROLOGY
7.11 HEMATOLOGY
7.12 OTHER
8 BLOOD PLASMA MARKET END USER ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET END USER ANALYSIS, 2015-2019
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 HOSPITALS
8.6 CLINICS
8.7 OTHER
9 BLOOD PLASMA MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 ЕХTЕNЅІVЕ ВURNЅ
9.6 МАЅЅІVЕ ВLООD ОR РLАЅMА LОЅЅ
9.7 НУРОVОLЕMІС ЅHОСK
9.8 OTHER
10 GLOBAL BLOOD PLASMA REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 SOUTH AMERICA
10.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 ВАХTЕR
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 СЅL
11.3 GRІFОLЅ
11.4 ОСTАРHАRMА
11.5 ВАУЕR
11.6 ВІОTЕЅT
11.7 КЕDRІОN
11.8 СВОР
11.9 RААЅ
11.10 НUАLАN ВІО
11.11 ТІАNTАN ВІО
11.12 ЅHUАNGLІN ВІО
11.13 ВОYА
11.14 OLYMPUS CORPORATION
11.15 MEDIVATORS INC.
11.16 GETINGE AB.
11.17 STERIS PLC.
11.18 BELIMED
11.19 PFIZER INC.
11.20 F. HOFFMANN-LA ROCHE LTD
11.21 MERCK & CO., INC.
11.22 ASP
11.23 ABBOTT.
11.24 BAYER AG
11.25 BD
11.26 BEMIS COMPANY, INC.
11.27 CANTEL MEDICAL.
11.28 MEDTRONIC
11.29 CROSSTEX INTERNATIONAL, INC.
11.30 DANAHER.
11.31 DIVERSEY, INC
11.32 SEALED AIR
11.33 SEMPERIT AG HOLDING
11.34 INFORMA PLC.
12 ABOUT US

TABLE 1 BLOOD PLASMA REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 2 GLOBAL BLOOD PLASMA MARKET, 2020–2030, (USD MILLION)
TABLE 3 BLOOD PLASMA CURRENT AND FUTURE REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 4 GLOBAL BLOOD PLASMA HISTORICAL MARKET TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 5 BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 6 GLOBAL BLOOD PLASMA HISTORICAL MARKET MODE OF DELIVERY ANALYSIS, 2015-2019, (USD MILLION)
TABLE 7 BLOOD PLASMA CURRENT AND FUTURE MODE OF DELIVERY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 8 GLOBAL BLOOD PLASMA HISTORICAL MARKET THERAPEUTIC INDICATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 9 BLOOD PLASMA CURRENT AND FUTURE THERAPEUTIC INDICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 10 GLOBAL BLOOD PLASMA HISTORICAL MARKET END USER ANALYSIS, 2015-2019, (USD MILLION)
TABLE 11 BLOOD PLASMA CURRENT AND FUTURE END USER ANALYSIS, 2020–2030 (USD MILLION)
TABLE 12 GLOBAL BLOOD PLASMA HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 13 BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 14 NORTH AMERICA BLOOD PLASMA HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 15 NORTH AMERICA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 16 NORTH AMERICA BLOOD PLASMA CURRENT AND FUTURE MODE OF DELIVERY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 17 NORTH AMERICA BLOOD PLASMA CURRENT AND FUTURE THERAPEUTIC INDICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 18 NORTH AMERICA BLOOD PLASMA CURRENT AND FUTURE END USER ANALYSIS, 2020–2030 (USD MILLION)
TABLE 19 NORTH AMERICA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 20 U.S. BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2015–2020
TABLE 21 U.S. BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 22 U.S. BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 23 CANADA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 24 CANADA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 25 MEXICO BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 26 MEXICO BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 27 APAC BLOOD PLASMA HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 28 ASIA-PACIFIC BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC BLOOD PLASMA CURRENT AND FUTURE MODE OF DELIVERY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC BLOOD PLASMA CURRENT AND FUTURE THERAPEUTIC INDICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC BLOOD PLASMA CURRENT AND FUTURE END USER ANALYSIS, 2020–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 33 CHINA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 34 CHINA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 35 JAPAN BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 36 JAPAN BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 37 KOREA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 38 KOREA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 39 INDIA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 40 INDIA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA BLOOD PLASMA HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA BLOOD PLASMA CURRENT AND FUTURE MODE OF DELIVERY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA BLOOD PLASMA CURRENT AND FUTURE THERAPEUTIC INDICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA BLOOD PLASMA CURRENT AND FUTURE END USER ANALYSIS, 2020–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 51 UAE BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 52 UAE BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 53 EGYPT BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 54 EGYPT BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 55 NIGERIA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 56 NIGERIA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 59 EUROPE BLOOD PLASMA HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 60 EUROPE BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 61 EUROPE BLOOD PLASMA CURRENT AND FUTURE MODE OF DELIVERY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 62 EUROPE BLOOD PLASMA CURRENT AND FUTURE THERAPEUTIC INDICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 63 EUROPE BLOOD PLASMA CURRENT AND FUTURE END USER ANALYSIS, 2020–2030 (USD MILLION)
TABLE 64 EUROPE BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 65 GERMANY BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 66 GERMANY BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 67 FRANCE BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 68 FRANCE BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 69 UK BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 70 UK BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 71 RUSSIA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 72 RUSSIA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 73 ITALY BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 74 ITALY BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 75 SOUTH AMERICA BLOOD PLASMA HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 76 SOUTH AMERICA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 77 SOUTH AMERICA BLOOD PLASMA CURRENT AND FUTURE MODE OF DELIVERY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 78 SOUTH AMERICA BLOOD PLASMA CURRENT AND FUTURE THERAPEUTIC INDICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 79 TABLE 82 SOUTH AMERICA BLOOD PLASMA CURRENT AND FUTURE END USER ANALYSIS, 2020–2030 (USD MILLION)
TABLE 80 SOUTH AMERICA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 81 BRAZIL BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 82 BRAZIL BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 83 ARGENTINA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 84 ARGENTINA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 85 COLUMBIA BLOOD PLASMA CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 86 COLUMBIA BLOOD PLASMA CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)